GLP-2 analog(Sciwind Biosciences)

N/A

Report date: 2024/10/30 15:18:10
NME

Base Information

Drug NameGLP-2 analog(Sciwind Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 2 receptor modulators
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Sciwind Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Sciwind Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsShort Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A